SCHEMBL12470651

SCHEMBL12470651

COC(=O)C1CCC=CCCCCN(C)C(=O)C2CCC(O)CC2C(=O)N1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.31
▸ LNPEP Q9UIQ6 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11904963 1.00 CTSB (0.31) CTSBLNPEP
SCHEMBL11905167 0.80 CTSB (0.32) CTSB
SCHEMBL12470399 0.80 CTSB (0.32) CTSB
SCHEMBL11905237 0.79 CTSB (0.34) CTSBLNPEP
SCHEMBL12470807 0.79 CTSB (0.34) CTSBLNPEP
SCHEMBL3054091 0.78 — —
SCHEMBL1927692 0.74 CTSB (0.46) CTSB
SCHEMBL11929778 0.74 CTSB (0.46) CTSB
SCHEMBL996663 0.73 ALDH1A1 (0.32) —
SCHEMBL11929776 0.71 CTSB (0.44) CTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012109398-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING HCV INFECTIONS IDENIX PHARMACEUTICALS, INC. (US) 2012-08-16 — — WO disclosed
Send feedback